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Identification of an H2-M3-Restricted
Listeria Epitope: Implications for
Antigen Presentation by M3
Laurel L. Lenz, Beverley Dere, C, enable Listeria to spread from cell to cell without
returning to the extracellular milieu (Kocks et al., 1992;and Michael J. Bevan
Howard Hughes Medical Institute Vazquez et al., 1992). These and other bacterial gene
products that access the host cytosol thus enter theDepartment of Immunology
University of Washington conventional MHC class Ia pathway of antigen pro-
cessing and presentation. Two secreted Listeria pro-Seattle, Washington 98195
teins have previously been shown to provide peptide
epitopes for MHC class Ia–restricted CD81 CTL: LLO
(residues 91–99) and p60 (residues 217–225 and 449–Summary
457) (Pamer et al., 1991; Pamer, 1994; Sijts et al., 1996).
CTLs specific for the LLO and p60 epitopes lyse infectedUsing expression cloning, we have identified an H2-
syngeneic target cells in vitro (Pamer et al., 1991; SijtsM3-restricted epitope of the intracellular bacterial
et al., 1996), and adoptive transfer of CTLs specific forpathogen Listeria monocytogenes. Picomolar con-
LLO(91–99) and p60(217–225) protects syngeneic micecentrations of an amino-terminal N-formylated hexa-
against subsequent Listeria challenge in vivo (Harty andpeptide, fMIGWII, targeted cells for lysis by CD81 cyto-
Bevan, 1992; Harty and Pamer, 1995).toxic T cells, while the nonformylated peptide was
Mice infected with Listeria have long been known toapproximately 100-fold less active. The sequence of
develop CD81 CTL responses that are not restrictedthe 185 aa protein source of this epitope predicts a
by conventional polymorphic MHC class Ia alleles (Detransmembrane protein that retains its N terminus and
Libero and Kaufmann, 1986). Such MHC-unrestrictedassumes an Nout–Cin topology. This membrane orienta-
CTLs adoptively transfer protection to allogeneic hoststion offers an explanation for the protection of the
(Kaufmann et al., 1988; Lukacs and Kurlander, 1989) andepitope from deformylases present in the bacterial cell
demonstrate antigen-specific lysis of both syngeneicand suggests an explanation for the ability of phago-
and allogeneic macrophage targets that are Listeria in-cytes to present H2-M3-restricted bacterial epitopes
fected or pulsed with heat-killed Listeria monocyto-via a vacuolar TAP-independent mechanism.
genes (HKLm) (De Libero and Kaufmann, 1986; Kauf-
mann et al., 1988; Lukacs and Kurlander, 1989; BrownIntroduction
et al., 1992). This MHC-unrestricted pattern of CTL rec-
ognition was explained by the finding that an MHC classGenes within the murine major histocompatibility com-
Ib gene with limited polymorphism, H2-M3, restricts theplex (MHC) encode an assortment of antigen-presenting
presentation of an unidentified Listeria-derived peptidemolecules. The conventional and highly polymorphic
to CTL effectors (Pamer et al., 1992). Similarly, the M3MHC class II and MHC class Iaalleles encode membrane
molecule (encoded by H2-M3) was implicated in presen-glycoproteins that bind antigenic peptide epitopes and
tation of a detergent-solubilized Listeria membrane anti-present these epitopes to CD41 or CD81 T lymphocytes,
gen to MHC-unrestricted CTLs (Kurlander et al., 1992).respectively. The peptide epitopes presented to CD41
Presentation both of this solubilized antigen and of un-T cells are largely processed from exogenous antigens
fractionated HKLm to CTLs had previously been shownand load MHC class II molecules within acidified vacuo-
to be inhibited by Brefeldin A, chloroquine, ammoniumlar compartments of antigen-presenting cells (APCs).
chloride, monensin, and pepstatin A (Brown et al., 1992).Conversely, the peptide epitopes presented to CD81
Thus, the pathway used for processing and presentationcytotoxic T lymphocytes (CTLs) are generally processed
of these complex Listeria antigens to H2-M3-restrictedfrom endogenous proteins by cytosolic or nuclear pro-
CTLs may incorporate features of the MHC class II path-teasomes. These cytosolic peptides are transported via
way of antigen processing and presentation.the heterodimeric transporter associated with antigen
H2-M3wt is the allele of H2-M3 present in most com-processing (TAP) into the endoplasmic reticulum (ER)
mon inbred mouse strains and is expressed in a varietylumen, where they associate with the peptide-binding
of tissues (Smith et al., 1994; Fischer Lindahl et al., 1991;groove of nascent MHC class Ia molecules. These anti-
Wang et al., 1991). H2-M3 was originally identified duegen presentation pathways thus limit the presentation
to its role in CTL responses to a maternally transmittedof most antigens derived from extracellular and vacuolar
minor histocompatibility antigen (Mta) (Fischer Lindahlpathogens to CD41 T cells, whereas antigenic peptides
et al., 1991). Studies with Mta-specific CTLs revealedfrom viruses and cytosolic intracellular bacteria are pre-
that the M3 molecule presents a hydrophobic peptidesented to CD81 CTL (Germain and Margulies, 1993; Wolf
derived from the N terminus of a mitochondrial protein:and Ploegh, 1995).
the ND1 subunit of NADH dehydrogenase (Loveland etThe gram-positive bacterium Listeria monocytogenes
al., 1990; Wang et al., 1991). The N-terminal formylmethi-is a facultative intracellular pathogen. Virulent Listeria
onine residue is essential for efficient presentation ofstrains express listeriolysin O (LLO), a hemolysin that
the ND1 peptide to Mta-specific CTLs (Shawar et al.,facilitates escape of phagocytosed bacteria into the
1990; Smith et al., 1994), and peptides that initiate withhost cell cytosol (Tilney and Portnoy, 1989). Once in the
N-formylmethionine efficiently block target cell lysis bycytosol, expression of other Listeria virulence factors,
such as the ActA gene product and a phospholipase these CTLs (Shawar et al., 1990, 1991; Vyas et al., 1992).
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Since only eubacteria, including mitochondria and chlo-
roplasts, initiate protein synthesis with N-formylmethio-
nine, these findings suggest that M3 may have evolved
to play a specialized role in host defense against bacte-
rial pathogens (Shawar et al., 1990, 1994; Pamer et al.,
1993).
A molecule specialized for presentation of antigens
from bacterial pathogens might well have evolved to
load antigens from the intracellular compartments
where bacteria reside. Consistent with loading of M3
in a vacuolar compartment, we provide evidence that
phagocytes present heat-killed bacteria to H2-M3-
restricted CTLs independent of an intact TAP trans-
porter. We also describe the use of an expression clon-
ing strategy to identify the first pathogen-derived Figure 1. Cb10 CTLs Are Restricted by H2-M3wt
epitope presented by M3. This epitope is derived from (A) Competition of fMet peptides for presentation to Cb10 CTL ef-
the hydrophobic N terminus of a novel Listeria mem- fectors. Shown is specific lysis of EL4 target cells coated with HPLC-
brane protein which is predicted to assume an Nout–Cin purified Fr40 plus the indicated concentrations of fMet (closed sym-
bols) or nonformylated (open symbol) competitor peptides. The E:Ttopology. We discuss the significance of this membrane
ratio used was 5:1. Lysis of Fr40-coated targets in the absence oftopology in terms of the selection of bacterial epitopes
competitors was 47.5%.for presentation by M3, and the possible mechanisms
(B) Effects of target cell MHC and b2m expression on presentationfor loading of the M3 molecule in a vacuolar com- to Cb10 CTL effectors. Target cells differing in MHC haplotype and
partment. b2m expression were coated with uninoculated bacterial culture
media (TSB; open symbols) or LmSN (closed symbols) and assayed
for lysis by Cb10 CTLs at the indicated E:T. EL4 (H-2b) and R1.1
Results (H-2k) cells express b2m. R1.E is a b2m-negative mutant of R1.1.
(C) Effects of H2-M3wt expression on presentation to Cb10 CTL
Previous reports of H2-M3-restricted presentation of effectors. Shown is lysis of TSB- (open symbols) or LmSN- (closed
symbols) coated B10.CAS2, TR8-4a, and control EL4 targets at theListeria antigen to T cell receptor (TCR)ab CD81 T cells
indicated E:T ratios. B10.CAS2 fibroblasts express a null H2-M3have noted that targeting activity can be detected in the
allele (H2-M3cas2), whereas TR8-4a transfectants and EL4 expresssupernatant of Listeria cultures (Pamer et al., 1992), or
H2-M3wt.
that heat-killed organisms can provide antigen to mac-
rophages (Kurlander et al., 1992). This is unlike the situa-
tion with conventional MHC class Ia–restricted presen-
allogeneic R1.1 (H-2k) target cells are lysed by Cb10 CTLtation of LLO and p60 epitopes, which requires infection
effectors (Figure 1B), indicating that antigen presenta-of cells with viable LLO-producing bacteria (Brunt et al.,
tion to Cb10 does not require conventional MHC class1990; Pamer et al., 1991). To generate new CTL lines
Ia or MHC class II molecules. However, R1.E target cells,that could recognize exogenous bacterial antigen, we
b2-microglobulin (b2m)-negative mutants of R1.1, do notused HKLm to stimulate splenocytes from a C57BL/6
present LmSN to Cb10 CTL effectors (Figure 1B). Thus,mouse previously primed by sublethal infection with via-
presentation of the Fr40 epitope to Cb10 CTLs requiresble virulent Listeria. CD81 cytolytic clones were isolated
expression of a b2m-dependent MHC class Ib molecule.by limiting dilution and the Cb10 clone (which expresses
The third line of evidence that H2-M3 restricts Cb10TCRab) was used for further study. The Cb10 CTL clone
CTL responses is presented in Figure 1C. LmSN-coatedrecognizes a hydrophobic epitope in natural peptide
B10.CAS2 fibroblasts, which express the (null) H2-M3casextracts of Listeria-infected macrophages, which elutes
allele, are not lysed by Cb10 CTLeffectors, but presenta-at fraction 40 (Fr40) on RP–HPLC. In addition, low molec-
tion of the Fr40 epitope is restored in an H2-M3wtular mass material in Listeria culture supernatants
transfectant of B10.CAS2 fibroblasts (TR8-4a; Wang et(LmSN) also contains targeting activity for the Cb10 CTL
al., 1991). These data provide direct proof that M3 isclone (see below). Supernatants of Escherichia coli, Sal-
responsible for presentation of Fr40 to Cb10 CTLs.monella typhimurium, or Bacillus subtilis, or sonicates
of these cultures, did not contain targeting activity.
Presentation of Exogenous HKLm Antigen
to Cb10 CTLsH2-M3 Restricts Cb10 CTL Responses
Three lines of evidence indicate that M3 presents the As mentioned above, Cb10 CTLs are restimulated in
vitro with HKLm as a source of bacterial antigen. Yet,Fr40 epitope to Cb10 CTL effectors. First, competitor
peptides initiating with N-formylmethionine (fMet pep- HKLm preparations do not contain viable bacteria and
thus have no obvious route of access to the conventionaltides) competitively inhibit lysis of Fr40-coated target
cells by Cb10 CTL effectors (Figure 1A). Competition of (cytosolic) MHC class Ia antigen presentation pathway.
To investigate more directly the presentation of HKLmFr40 presentation by the corresponding nonformylated
competitor requires at least 100-fold higherpeptide con- to H2-M3-restricted CTLs, we compared the ability of
LmSN and washed preparations of HKLm to elicit lysiscentration (Figure 1A), which is consistent with the pref-
erential presentation of fMet peptides by M3 (Shawar of target cells by Cb10 CTL effectors (Figures 2A and
2B). Predictably, the LmSN antigen elicited CTL lysis ofet al., 1990; Smith et al., 1994). Second, LmSN-coated
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Figure 3. TAP-Independent Presentation of HKLm to Cb10 CTLs
Target cells were labeled with 51Cr and precoated with (A) 50 ml of
LmSN or (B) dilutions of HKLm and assayed for lysis in a 4 hr CTL
assay with Cb10 CTL effectors at an E:T of 5:1. BMMs were culturedFigure 2. Phagocytic Cells Present Exogenous HKLm Antigen to
from wild-type C57BL/6 mice (B6 BMM) or from Tap-18 mice (TAP8Cb10 CTLs
BMM) in L cell–conditioned medium. Lysis of target cells in the51Cr-labeled target cells were precoated for 2 hr with (A) 50 ml of
absence of Cb10 effectors was less than 5% at all moi.LmSN or (B) an equal volume of HKLm washed and diluted in PBS.
Cb10 CTL effectors were added at an E:T of 5:1 and lysis was
measured in a 4 hr CTL assay.
may shed light on the mechanics of this TAP-indepen-
dent pathway of HKLm presentation.
both J774 macrophages and nonphagocytic EL4 thy-
moma cells, P815 mastocytoma cells, and M12A2 B A Library for Expression Cloning
of Listeria Antigenscells (Figure 2A). Thus, all three cell types clearly express
M3 molecules that load with Listeria peptides present To gain insight into the nature of bacterial antigens pre-
sented by M3, we sought to use an expression cloningin LmSN. However, Cb10 CTL effectors fail to kill EL4,
P815, or M12A2 targets that are incubated with HKLm, technique to identify bacterial antigens presented to
H2-M3-restricted CTLs. We screened for expression ofdespite the observation that macrophage targets readily
present the exogenous HKLm antigen in a dose-depen- Fr40 activity by E. coli transformed with a Listeria geno-
mic library. The library was prepared by cloning Listeriadent manner (Figure 2B). Furthermore, target cells incu-
bated with HKLm are not lysed in the absence of CTLs genomic DNA fragments into a shuttle vector, pAT29
(Trieu et al., 1990). This vector was chosen because it(Figure 2B), demonstrating that HKLm is not toxic to
the phagocytic cells. Together, these data suggest that permits shuttling of the library between gram-negative
and gram-positive hosts, if required for appropriate ex-HKLm preparations do not contain high concentrations
of soluble targeting activity, and that macrophages can pression of Listeria gene products.
The library is comprised of 3084 individual E. coliprocess HKLm to obtain Fr40-like determinants for pre-
sentation to H2-M3-restricted CTLs. transformants, which have an average insert size of
5.7 6 1.3 kb, as estimated from 31 randomly selectedTo evaluate whether processing and presentation of
HKLm by macrophages utilizes components of the con- clones. Thus, the sum of Listeria DNA in the library repre-
sents approximately 6 genomes, assuming 3,150 kb/ventional MHC class Ia antigen presentation pathway,
we assayed for presentation of LmSN and HKLm by genome (Michel and Cossart, 1992). The completeness
of the library was further evaluated by determining thebone marrow–derived macrophages (BMMs) cultured
from wild-type C57BL/6 (B6), or Tap1-deficient (TAP8) representation of two unlinked single copy Listeria
genes: the LLO-encoding gene hly and the p60-encod-mice (Figures 3A and 3B). B6 BMMs present both LmSN
and HKLm antigens to Cb10 CTLs (Figures 3A and 3B), ing gene iap. Using a polymerase chain reaction (PCR)-
based assay the library was screened in pools of 96confirming that primary phagocytes process and pres-
ent exogenous bacterial antigen to H2-M3-restricted clones. Based on amplification of PCR products of the
appropriate sizes, 11 of 33 pools scored positive for hlyCTLs. Furthermore, presentation of HKLm occurs inde-
pendent of functional TAP heterodimers, since HKLm- and 2 of 33 pools were positive for iap. Assuming that
each positive pool contains a single positive trans-coated TAP8 BMMs were also lysed by Cb10 CTLs (Fig-
ure 3B). It is clear, however, that antigen-coated TAP8 formant, the frequency of hly-positive clones is esti-
mated at 3.6 3 1023, while iap appears at a frequencyBMMs are less-efficiently lysed than are B6 BMMs. This
reduced lysis may reflect reduced surface expression of 6.5 3 1024. These data indicate that both test genes
are present in this Listeria expression library, althoughof peptide-receptive MHC class I molecules in the ab-
sence of TAP (Day et al., 1995), or it may indicate that some individual Listeria genes may be over or underrep-
resented.HKLm presentation occurs via a TAP-dependent path-
way as well. Interestingly, the proliferative responses of
Cb10 CTLs in response to HKLm-coated B6 and TAP8 Identification of Transformants that
Produce Fr40 Activitysplenocytes are nearly equivalent (Lenz and Bevan,
1996), which may indicate delayed release or loading To screen for E. coli transformants potentially express-
ing the Fr40 epitope, the specific lysis of J774 macro-of Fr40 in the absence of TAP. Thus, identification of
bacterial antigens presented to H2-M3-restricted CTLs phages coated with lysates of E. coli transformants was
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Table 1. Identification of Transformant Clones that Produce CTL
Targeting Activity
Percent Specific Lysis
Transformant Cb10 CTL No CTL
pAT29a 12 8
Group 1
Bb5 91 100
Ld10 81 86
Ne5 95 95
Nh12 100 94
Ph8 100 95
Pg12 98 98
7Cf2 85 89
Group2
Aa12 84 24
Lg10 66 8
Pb12 74 14
Qe11 83 8
Rc5 80 12
Vf8 70 16
7Ca10 77 9
7Cg3 82 9
7Da9 79 14
7Eg1 71 0
7Fe5 71 0
7Gb9 66 9
7He3 77 9
Figure 4. Restriction Map of pQe11 and Partial Nucleotide Se-
a E. coli transformed with the parental pAT29 plasmid. quence of the Putative Lem Operon
(A) Insert DNA from the pQe11 plasmid was mapped with the indi-The library was screened for targeting activity and 18 active pools
cated enzymes: Sp, SphI; P, PstI; H, HindIII; E, EcoRI. Individualwere identified. The transformant clones comprising these active
restriction fragments were subcloned into pUC19 and subclonespools were assayed individually for Fr40 production by screening
were tested for production of Fr40-like activity. Activity segregatedfor target cell lysis with or without addition of Cb10 CTL effectors
with the highlighted 0.4 kb H–P fragment. Numbers indicate sizes (inat an E:T of 10:1. Those clones whose lysates elicited . 20% lysis
kilobases) of the indicated restriction fragments. The pAT29 multipleof J774 targets are shown. Transformants in group 1 likely express
cloning site (MCS) is represented by closed boxes at each end oftoxic Listeria-encoded products; those in group 2 express Fr40-like
the insert. Indicated below the map are the positions of the z1.2activity (see text).
kb P–P and z1.8 kb Sp–Sp inserts of subclones pE1D and pID6.
(B) Partial nucleotide sequence from the Listeria insert DNA of pE1D
and pID6. Double-underlined bases represent nucleotides that fit
consensus sequences for binding of RNA polymerase (235 andmeasured in CTL assays with Cb10 CTL effectors. J774
210). Single underlines designate ribosome-binding sites (rbs). Boldmacrophage targets were used to facilitate any required
italics indicate the PstI (CTGCAG) and HindIII (AAGCTT) restriction
processing of Listeria-encoded antigens in the E. coli sites, which flank the 0.4 kb fragment to which the Fr40 epitope was
lysates. These lysates were first screened in pools repre- mapped (see text). The nucleotide sequence predicts a polycistronic
senting 8 transformant clones per pool, and Cb10 CTL transcript encoding at least two polypeptides (LemA and LemB).
Translations for the LemA coding region and the N terminus of LemBeffectors were added to each pool. Of the 386 pools
are given using the single letter amino acid code. The predictedtested, 18 active pools elicited specific lysis of J774
LemA membrane-spanning domain is indicated by a dotted under-cells which was $10% above the level of background
line. Positively charged residues used to predict the membrane
lysis seen in the presence of control E. coli lysates (data orientation of LemA are indicated at positions 27, 29, and 31 with
not shown). These active pools represented 144 individ- a plus symbol. Amino acid residues in bold type represent the se-
ual clones. A screen of lysates prepared from individual quence of the LemA hexapeptides used in Figure 6, and an asterisk
indicates the stop codon for the LemA protein. The coding sequenceclones in these pools revealed 20 active clones, which
for LemB continues at least 103 residues and runs into the multipleare listed in Table 1. Seven of these clones (Table 1,
cloning site (data not shown). The positions of the 59 (396revF) andgroup 1) caused target cell lysis in the absence of Cb10
39 (189Fwd) oligonucleotide primers used in Figure 5 are also shown.
CTLs; presumably these clones produce a Listeria pro-
tein that is toxic for J774 macrophages. However, the
remainder of the active clones (Table 1, group 2) appear in the library screen, we isolated plasmid DNA from
to express a Listeria gene or genes that mark the target one such transformant (Table 1, Qe11) and generated
cells for destruction by Cb10 CTL effectors. This sug- a restriction map of the insert. The insert in this plasmid
gests that the latter group includes clones that express (pQe11) was approximately 5 kb long and contained
a Listeria gene or genes that give rise to the Fr40 epitope. seven restriction sites that could be unambiguously
mapped (Figure 4A). By multiple digestions of pQe11
we subcloned six fragments into pUC19. Two additionalSubcloning and Sequencing of a Candidate Gene
To focus our search for Listeria genes responsible for subclones were generated by excising fragments from
pQe11 and reannealing the plasmid. Thus, eight distinctFr40 production in the E. coli transformants identified
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restriction fragments were subcloned. For each sub-
clone, lysates of several insert-bearingtransformant col-
onies were tested for targeting activity using J774 tar-
gets and Cb10 CTL effectors. Fr40-like activity was
detected in lysates from five subclones, whereas no
activity was detected in lysates of the remaining sub-
clones. Furthermore, all Fr40-positive subclones shared
a 0.4 kb PstI–HindIII (P–H) fragment, which was absent
in the inserts of subclones that did not produce Fr40
activity. These data suggested that this 0.4 kb P–H frag-
ment contained a Listeria gene or gene fragment that
permitted expression of Fr40 activity in E. coli trans-
formants.
To identify Listeria genes present in the 0.4 kb P–H
fragment, we sequenced two active subclones. These
plasmids, pE1D and pID6, carried pQe11-derived inserts
of z1.2 kb and z1.8 kb, respectively, which overlapped Figure 5. The N-Terminal Coding Region of lemA Is Present in All
the active P–H fragment (Figure 4A). Analysis of the 0.4 Transformants that Produce Fr40 Activity
kb sequence revealed five open reading frames (ORFs) lemA-specific PCR primers (lanes 1–15) were used to amplify prod-
ucts from the following template DNAs: plasmid DNA isolated fromwith potential polypeptide products of greater than 15
each Fr40-producing transformant listed in group 2 of Table 1 (lanesaa. We synthesized decameric fMet peptides corre-
1–13), pAT29 plasmid (lane 14), and Listeria genomic DNA (lane 15).sponding to the N termini of these ORFs and tested
The 396revF and 189Fwd primers were used to detect the 59 end
each peptide for Fr40-like activity in CTL assays using of the lemA gene anneal as indicated in Figure 4 and amplify a 223
Cb10 CTL effectors. Remarkably, the fMet peptide cor- bp product. Lane 16 contains molecular mass standards.
responding to one Listeria-encoded ORF (329Fwd ORF)
triggered dose-dependent CTL lysis of EL4 target cells
at nanomolar concentrations, whereas even 10 mM con-
consensus signal peptidase cleavage site, suggesting
centrations of the other four peptides had no activity
that its N terminus remains intact. Instead, the protein is
(data not shown). This Listeria-encoded peptide thus
predicted to have a single membrane-spanning domain,
demonstrated Fr40-like activity. The DNA 59 of the ORF
which orients in the membrane with an Nout–Cin topologyencoding this peptide contained appropriately spaced
and retains its N terminus. This prediction is based onbacterial RNA polymerase (210 and 235 sites) and ribo-
the presence of an N-terminal hydrophobic domain (thesome (rbs)-binding sites, consistent with its expression
N-terminal 20–26 residues), which is followed by severalin Listeria. However, database searches with the trans-
positively charged residues (positions 27, 29, and 31).
lated 329Fwd ORF sequence failed to identify homolo-
In accordance with the positive–inside rule (von Heijne,
gous gene products, suggesting that this ORF repre-
1986), the charged residues following position 26 and
sents a previously unidentified Listeria gene. Together,
the remainder of the LemA polypeptide should remain
these data identify this novel gene as a good candidate
within the bacterial cytosol. This topology places the
for the Fr40-encoding gene, and we hereafter refer to it
N-terminal formylmethionine of LemA at the exterior (ex-
as lemA, for Listeria epitope with M3.
tracytosolic) face of the bacterial plasma membrane.
Detection of lemA in All Fr40-ProducingLemA and the Putative lem Operon
To gain insight into the subcellular localization of the Library Transformants
As noted above, screening of the Listeria library withLemA protein, we completed sequencing of the lemA
gene and surrounding DNA. Analysis of nucleotide se- Cb10 CTLs identified 13 E. coli transformant clones that
expressed Fr40 activity (Table 1). Partial mapping of thequence obtained from two subclones (Figure 4A, pE1D
and pID6) suggests that lemA is transcribed as the first recombinant plasmids from these clones revealed at
least 9 distinct species (data not shown). To determinegene of a polycistronic transcript (see Figure 4B). Using
the BLAST server at the National Center for Biotechnol- whether the candidate Fr40-encoding gene was present
in each of these heterogeneous plasmids, we assayedogy Information, we failed to identify any protein se-
quences in the nonredundant protein sequence data- for amplification of a diagnostic PCR product using
lemA-specific oligonucleotide primers.The PCR primersbase that share extensive homology with LemA.
However, analysis of the predicted LemA amino acid used (396revF and 189Fwd; see Figure 4B) amplify 119
bp at the 59 end of the lemA coding sequence plus ansequence reveals a single N-terminal hydrophobic re-
gion of 20–26 hydrophobic residues. Cleaved signal additional 64 bp of upstream DNA to yield a 223 bp
product. These primers clearly amplify a single productpeptides of secreted prokaryotic proteins typically have
an N-terminal basic region followed by a stretch of hy- of the predicted size from a Listeria genomic DNA tem-
plate (Figure 5, lane 15). Conversely, identical PCR con-drophobic residues, a polar region, and a consensus
cleavage site for signal peptidase (Simonen and Palva, ditions failed toamplify this product from pAT29 plasmid
control DNA (Figure 5, lane 14), as expected for specific1993; Pugsley, 1993). The LemA N terminus lacks basic
residues before the hydrophobic stretch as well as a amplification of the Listeria lemA gene. Detection of this
Immunity
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that one or both of these peptides comprises the Fr40
epitope.
Discussion
Taking advantage of the fact that L. monocytogenes
releases targeting activity for H2-M3-restricted CTLs
into bacterial culture supernatants (Figure 1; Pamer et
al., 1992) and that phagocytes such as J774 can process
heat-killed organisms for presentation to such CTLs, we
devised an expression cloning strategy to identify one
of these Listeria epitopes. Pools of E. coli transformed
with a Listeria genomic library were grown, freeze-
thawed and “fed” to 51Cr-labeled J774 targets in the
presence of Cb10 CTLs. Transformant clones producing
CTL-dependent targeting activity all encoded the N ter-
Figure 6. fMet Peptides Corresponding to the N Terminus of LemA minus (and presumably the promoter region) of the novel
Efficiently Target Lysis by Cb10 CTLs protein LemA. The N-formylated hexamer fMIGWII and
Stocks of synthetic peptides corresponding to the N-terminal 5, 6, heptamer fMIGWIIA synthetic peptides serve as efficient
7, or 8 residues of LemA were diluted in PBS and coated onto
epitopes for these CTLs, causing significant lysis of tar-EL4 targets at the indicated final concentrations. All peptides were
gets at 10211 M concentrations. The pentameric peptidesynthesized with an N-formylmethionine (fM), except for LemA (1–6),
is 100- to 1000-fold less active, and the octameric pep-which was synthesized with an unformylated methionine. Peptide-
coated targets were assayed for lysis in a 4 hr CTL assay with Cb10 tide is 10-fold less active. In line with previous work on
CTL effectors at an E:T of 5:1. Specific lysis of peptide-coated another epitope for H2-M3-restricted CTLs, the formyl-
targets in the absence of CTLs was less than 5%. ated N terminus of the ND1 subunit of mitochrondrial
NADH, the deformylated hexamer LemA peptide, is
lemA-specific PCR product using plasmid DNA tem- about 100-fold less active. Thus, the formyl group con-
plates isolated from all 13 Fr40-producing clones indi- tributes much of the energy for anchoring of these hy-
cates that the 59 coding region of lemA is present in drophobic peptides to the M3 groove (Vyas et al., 1995;
each clone (Figure 5, lanes 1–13). These data support Wang et al., 1995). The nature of this anchoring was
the notion that only one region of the Listeria genome recently elucidated in the crystal structure of M3 com-
(lemA) produces targeting activity for Cb10 CTLs. plexed with a nonameric mitochondrial peptide (Wang
et al., 1995). In this crystal structure, peptide residues
Presentation of LemA Peptides to Cb10 CTLs 8 and 9 were seen to extend out of the M3 groove, which
The natural ligands for conventional MHC class Ia mole- is consistent with our functional data showing that a
cules are generally 8–10 residue peptides that elicit tar- 6- or 7-mer is most effective for targeting CTLs. We
get cell lysis when present in picomolar concentrations conclude that the formylated 6- or 7-mer LemA peptides
(Germain and Margulies, 1993). The optimal peptide size represent the natural Fr40 epitope, which is presented
for presentation by M3 is unknown, although peptides to H2-M3-restricted CTLs during Listeria infection.
as short as 6 residues target some ND1-specific CTLs During or rapidly following synthesis of most bacterial
(Shawar et al., 1990), and 3- or 4-mer chemotactic fMet proteins, the formyl group is removed from the nascent
peptides block H2-M3-restrictedpresentation of Listeria polypeptide by a cytosolic deformylase (Meinnel et al.,
peptides (see Figure 1; Pameret al., 1992). Toinvestigate 1993). The predicted topology of LemA explains how
theeffect of peptide length onthe efficiency of presenta- the N terminus of this protein avoids such deformylation.
tion to the H2-M3-restricted Cb10 CTLs, we assayed The N terminus of the protein is predicted to orient
CTL lysis of EL4 targets coated with titrated concentra- towards the outside of the bacterium (Nout), while the C
tions of 5, 6, 7, and 8 residue peptides corresponding terminus should remain within the bacterial cytosol (Cin).
to the LemA N terminus (Figure 6). The peptide concen- Thus, when LemA is assembled in the membrane, its
tration required to elicit half-maximal lysis of targets extracytosolic N terminus should be protected from the
coated with the N-formylated pentapeptide is z3–10 deformylase activity of the bacterial cytosol. Consistent
nM, which is z30 times that required for the N-formyl- with this prediction, the N-formylmethionine residue is
ated 8-mer peptide (Figure 6). The N-formylated 6- and retained in other bacterial membrane proteins with ex-
7-mer peptides were the most active species, were tracytosolic N termini (Wolfe et al., 1983; Vianney et al.,
nearly identical in their ability to bind M3 and be recog- 1994). It was also shown that genetic alteration of a
nized by Cb10 CTLs, and targeted lysis at concentra- model E. coli membrane protein from an Nout to an Nin
tions of 10 pM. The presentation of a nonformylated topology resulted in removal of the formylmethionine by
6-mer peptide corresponding to the first 6 residues of cytosolic enzymes (von Heijne, 1989). Thus, the pool of
LemA was also evaluated; the nonformylated peptide bacterial proteins that provide epitopes for presentation
was approximately 100-fold less active than the formyl- by M3 may largely be composed of membrane proteins
ated version. These data indicate that the N-terminal with extracytosolic N-terminalmethionine residues. This
6 and 7 residues of the formylated LemA protein are pool would include membrane proteins that assume a
presentedto Cb10 CTLs at 10- to300-fold lower concen- simple Nout–Cin topology (i.e., a single membrane-span-
ning domain), as well as those assuming more complextrations than are longer or shorter peptides, suggesting
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Nout topologies (i.e., multiple membrane-spanning do- presentation of HKLm, TAP may still transport cytosolic
Fr40 to the ER during infection of cells with viable LLO-mains). In this light, it is worth noting that the hydropho-
bic N terminus of the mitochondrial ND1 protein is not positive Listeria, particularly since it has been shown
that presentation of the mitochondrial ND1 epitope bythought to be cleaved from the protein (Fischer Lindahl
et al., 1991) and, like that of LemA, does not resemble M3 is TAP dependent (Attaya et al., 1992). Thus, in addi-
tion to its broad tissue distribution and selective bindinga cleaved signal sequence. Furthermore, the presence
of positively charged residues at positions 25 and 26 of of fMet peptides, M3 may have evolved the ability to
acquire peptides in both cytosolic (TAP-dependent) andthe ND1 protein sequence suggests that this protein
assumes an Nout topology, possibly contributing to H2- vacuolar (TAP-independent) compartments. Such load-
ing may enable H2-M3-restricted CTLs to recognize Lis-M3-restricted presentation the N-terminal ND1 epitope.
In addition to protection of the formyl group, the topol- teria-infected cells both prior to and following escape
of the bacterium into the host cell cytosol, and may thusogy of LemA may also contribute to the generation and
presentation of the Fr40 epitope during growth of Liste- suggest that these CTLs are an early component of
the host response to Listeria. Additionally, the ability toria in vitro and in vivo. Thus, the Fr40 activity detected
in bacterial cultures may arise from clipping the LemA acquire peptides from phagocytic vacuoles suggests
that M3 may play a role in presentation of antigens fromN terminus by extracellular proteases. Such cleavage
may be a rather inefficient and imprecise process, as both cytosolic and vacuolar bacterial pathogens.
It is interesting to note that Nataraj et al. (1996) havewe observe multiple distinct peaks of Fr40-like activity
in HPLC-fractionated LmSN (data not shown). In this recently reported a biochemical analysis of another hy-
drophobic Listeria antigen that is recognized by H2-case, each peak may represent a differentially pro-
cessed form of the LemA N terminus. Conversely, the M3-restricted CTLs. This antigen can be extracted from
bacterial membranes with detergent, and appears toFr40 activity that elutes from natural peptide extracts of
infected cells is more homogeneous (data not shown), resist degradation by a number of proteases. However,
bioactivity is lost in extracts treated with sodium perio-suggesting that cellular proteases can also play a role
in processing the LemA N terminus. It is unclear whether date, leading the authors to conclude that the antigen
may be a glycolipid. It has recently become clear thatsuch host enzymes can process the Fr40 epitope di-
rectly from the intact LemA molecule, or whether initial a human class I–like molecule, CD1b, presents hy-
drophobic lipid-containing moieties (mycolic acid andcleavage by bacterial proteases is required.
Data presented in Figures 2 and 3 show that a TAP- lipoarabinomannan) to T cells (Beckman et al., 1994;
Sieling et al., 1995). These antigens, which are associ-independent mechanism exists whereby phagocytic
cells process and present heat-killed bacteria to H2- ated with the cell walls of Mycobacterium tuberculosis
and Mycobacterium leprae, appear to be processed andM3-restricted CTLs. Other reports have also described
TAP-independent presentation of phagocytosedprotein presented in a TAP-independent pathway that requires
endosomal acidification (Porcelli et al., 1992; Sieling etantigens or peptide-coated beads by MHC class Ia mol-
ecules (Bachmann et al., 1995; De Bruijn et al., 1995). al., 1995). Together, these results may indicate that in
mice (which lack a homolog to human CD1b) M3 evolvedAkin to the model proposed by De Bruijn et al., we have
previously argued that the presentation of HKLm to H2- to fill a niche similar to that occupiedby CD1b inhumans.
Thus, inasmuch as M3 may present both hydrophobicM3-restricted CTLs may occur via loading of peptide-
receptive M3 molecules within phagocytic vacuoles fMet peptides and glycolipids to the immune system,
CD1b may present both glycolipids and hydrophobic(Lenz and Bevan, 1996). If this is the case, we envision
two ways in which the Nout topology of LemA may facili- peptides. However, proof of this hypothesis awaits the
identification of CD1b-restricted peptide ligands andtate such loading. The first mechanism assumes that
presentation of HKLm requires proteolytic processing H2-M3-restricted glycolipids.
of intact LemA molecules that remain associated with
the heat-killed particles. In this scenario, the Nout topol-
Experimental Proceduresogy of LemA may facilitate access of phagosomal prote-
ases to the LemA N terminus, promoting excision of the
Reagents and Materials
Fr40 epitope. The excised epitope might then readily Chemical reagents were purchased from Sigma Biochemicals (St.
load peptide-receptive M3 molecules and be shuttled Louis, Missouri) unless otherwise noted. Restriction endonucleases
to the macrophage surface. The second mechanism as- were purchased from GIBCO–BRL (Grand Island, New York) and
NEB (Beverly, Massachusetts). Oligonucleotide primers for PCR andsumes that the Fr40 activity in HKLm preparations is
sequencing were synthesized by Genset Corporation (La Jolla,comprised of bacterially processed LemA N-terminal
California). The chemotactic peptide, formyl–Met–Leu–Phe–Phefragments, which remain tightly associated with the Lis-
(fMLFF), was purchased from Sigma Biochemicals. Synthesis of
teria membrane throughout the heat-killing process. In MLFF and the ND1b peptide (residues 1–11) is described elsewhere
this case, the protruding LemA N terminus may directly (Pamer et al., 1992). Peptides representing the N terminus of LemA
bind peptide-receptive M3 molecules, causing their re- were synthesized on a model 432A Synergy peptide synthesizer
from the Applied Biosystems Division of Perkin Elmer. For synthesislease from the bacterial membrane. While both mecha-
of fMet peptides, empty cartridges were purchased and loaded withnisms may contribute to processing and presentation
75 mM formyl–Met–OH (Bachem Bioscience, Incorporated, King ofof HKLm by phagocytes, unrelated results may support
Prussia, Pennsylvania). Aliquots of LemA peptide variants were
the former mechanism. The data of Brown et al. (1992) stored at 2208C as 50 mM stocks in 50% acetonitrile and diluted in
suggest that presentation of HKLm to MHC-unrestricted phosphate-buffered saline (PBS) prior to use. The Micro BCA Protein
CTLs is pepstatin A sensitive and requires endosomal Assay Reagent Kit (Pierce, Rockford, Illinois) was used to determine
peptide concentrations.acidification. However, despite the TAP-independent
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Bacteria and Bacterial Antigens peptide variants and competitor peptides were diluted from stocks
into PBS. When used in CTL assays, frozen aliquots of HKLm wereVirulent Listeria monocytogenes strain 43251 was obtained from
the American Type Culture Collection (Rockville, Maryland), and thawed and organisms were washed twice and resuspended in PBS.
The multiplicity of infection (moi) of HKLm was calculated from theL. monocytogenes 10403S was provided by M. Strom (Northwest
Fisheries Science Center, Seattle, Washington). E. coli strain DH10B absorbance of washed HKLm by assuming 0.1 A600 represented 2 3
108 heat-killed organisms per ml.was purchased from GIBCO–BRL (Grand Island, New York).
Bacteria were cultured at 378C in trypticase soy broth (TSB; Difco
Laboratories,Detroit, Michigan) for antigen preparation and in Luria– Listeria Genomic Library
Bertani broth (LB) for DNA manipulation. L. monocytogenes strain Listeria 10403S genomic DNA was prepared from 14 hr cultures as
10403S is streptomycin resistant and was cultured in 100 mg/ml described (Flamm et al., 1984), partially digested with Sau3AI, and
streptomycin. E. coli transformants were grown in 100 mg/ml specti- electrophoresed on 0.6% agarose gels. DNA fragments of 5.0–10.0
nomycin (for pAT29-based vectors) or ampicillin (for pUC19-based kb were isolated from gel slices using the QIAEX DNA extraction
vectors). kit (QIAGEN, Incorporated, Chatsworth, California) and incubated
HKLm, was prepared from bacteria that were pelleted from a with Klenow enzyme plus dATP and dGTP to partially fill 39 over-
stationary (48 hr) culture of L. monocytogenes at 6,750 3 g. Listeria hangs as described (Sambrook et al., 1989). These inserts were
pellets were washed twice in PBS, then incubated at 678C for 3 hr. ligated to SalI-digested pAT29 madecomplementary by partial filling
Aliquots at z5 3 108 HKLm per ml were stored at 2808C. Low of 59 overhangs with dTTP and dCTP. Recombinant plasmids were
molecular mass L. monocytogenes culture supernatants (LmSN) electroporated into E. coli DH10B and plated on LB agar containing
were prepared by filtration through size-exclusion membranes with spectinomycin, IPTG, and X-gal. White transformants were picked
a 10 kDa cutoff as described (Pamer et al., 1992). Natural peptide and individually seeded in 96-well flat-bottomed plates and ex-
extracts were prepared from Listeria-infected J774 macrophages panded overnight at 378C without shaking. Transformants were
andfractionated on RP-HPLC using a C18 matrix and trifluoroactetic stored at 2808C as 15% glycerol stocks in 384-well plates (Nunc,
acid/acetonitrile gradients as described (Pamer et al., 1992). Experi- Incorporated, Naperville, Illinois).
ments using both Cb10 and JI1.4 CTL effectors (provided by E. G.
Pamer, Yale University, New Haven, Connecticut) showed that the PCR Screening
epitope recognized by Cb10 CTLs (Fr40) did not coelute with that hly and iap were detected in E. coli library transformants by PCR
seen by JI1.4 CTLs (Fr38). amplification of hly-specific or iap-specific bands from lysates of
bacteria pools. Primers used to detect hly were 59-GGCCCCCTCCT
TTGATTA and 59-CGTGTGTGTTAAGCGGTT, and they amplify a 1.8Cell Lines and CTLs
kb band. Primers for iap were 59-CATCCTCCATACCTTCTA andEL4 (H-2b) thymoma, P815 mastocytoma (H-2d), J774 macrophage
59-CTTCATCATACACCGTCT and they amplify a 2.0 kb band. Both(H-2d), R1.1 thymoma (H-2k), and R1.E (H-2k) all express H2-M3wt.
primer sets amplify across upstream regions and through codingB10.CAS2 fibroblasts (H-2cas2) express a null allele of H2-M3. TR8-
sequence. Individual positive clones were identified by screening4a is an H2-M3wt transfectant of B10.CAS2 (Wang et al., 1991).
subpools of positive pools with the same primer pairs. DiagnosticM12A2–I-Ab (labeled M12A2 in Figure 2) is an I-Ab transfectant of
restriction enzyme digests of the amplified hly PCRproduct resultedan H-2d B cell line and was provided by A. R. Rudensky (University
in the predicted fragment sizes in 4 of 4 clones. Western blots withof Washington, Seattle, Washington). Cell lines were grown in RP10
antisera specific for p60 (provided by E. G. Pamer, Yale University,medium (RPMI 1640 supplemented with 10% fetal bovine serum,
New Haven, Connecticut; Villanueva et al., 1994) confirmed p6050 mM 2-mercaptoethanol, L-glutamate, penicillin, gentamicin, and
expression by both iap-positive clones.streptomycin). Transfectant cell lines were cultured in RP10 supple-
To detect lemA in Fr40-positive clones, the primer pair 396revFmented with 400 mg/ml G418. BMMs were cultured from the bone
(59-AAATCTCATGCTGCAGTAGG) and 189Fwd (59-AATCTACGTTTAmarrow of C57BL/6 or Tap-18 mice as described (Brunt et al., 1990),
ATTGCACG) was used, which specifically amplifies a 223 bp prod-using L cell–conditioned media as a source of M-CSF. Breeding
uct. Amplification of sequence from the spectinomycin resistancepairs of Tap-18 mice were obtained from A. Berns (The Netherlands
gene (spc) of pAT29 served as a positive control for the PCR. SizeCancer Institute, Amsterdam, The Netherlands) and maintained in
markers in Figure 5 were purchased from GIBCO–BRL (wX174 RFour colony at the University of Washington.
DNA–HaeIII fragments).CTLs were cultured from CD81-enriched splenocytes of C57BL/
6 mice 7 days after intravenous infection with 5000 cfu L. monocyto-
genes 43251. Enrichment of CD81 cells and in vitro stimulation with Screening of the Library for Fr40-Producing Transformants
HKLm were as described (Brown et al., 1992). In brief, Listeria- E. coli transformants were cultured 24 hr with the appropriate antibi-
immune splenocytes were panned on plates coated with an anti- otic in 96-well flat-bottomed plates without shaking, transferred to
CD8 monoclonal antibody (3.168; Sarmiento et al., 1980). Adherent 96-well round-bottomed plates (50 ml/well), then lysed by three cy-
cells were stimulated in upright T-25 Falcon flasks (Beckton Dickin- cles of freeze-thawing. 51Cr-labeled J774 target cells were added
son Labware, Franklin Lakes, New Jersey) containing 1 ml HKLm, to thawed lysates and incubated 2 hr at 378C prior to addition of
and 3 3 107 irradiated syngeneic splenocyte stimulators. CTLs were Cb10 CTL effectors at an E:T of 10:1. A standard 4 hr CTL assay
cloned by limiting dilution; the Cb10 CTL clone was maintained by was performed and specific lysis was calculated using a published
restimulation with HKLm antigen and irradiated syngeneic spleno- formula (Moore et al., 1988). The library was originally screened
cytes at 7–10 day intervals. CTLs were cultured in RP10 supple- in pools of eight transformants. Lysates prepared from individual
mented with 5% supernatant from 1 day concanavalin A–stimulated transformants were then assayed to identify positive E. coli clones
rat splenocytes and 50 mM a-methyl mannoside. within these pools, which demonstrated $20% specific lysis. Indi-
vidual clones from active subpools were screened with and without
addition of Cb10 CTL effectors to CTL assays.CTL Assays
Target cells were labeled with 51Cr for use in standard 4 hr CTL
Subcloning of Listeria DNA Encoding Fr40 Activityassays as described (Pamer et al., 1992). In brief, 104 labeled target
Plasmid DNA was prepared from library clone Qe11 using a QIAGENcells (in RP10 media) wereadded perwell of 96-well round-bottomed
Plasmid Mini Kit (QIAGEN) and mapped according to standard pro-plates and preincubated 1–2 hr at 378C with 50 ml of the respective
cedures (Bloch, 1987). Selected restriction fragments were sub-antigen preparation. Following this preincubation, CTL effectors
cloned into pUC19 and lysates of these E. coli subclones werewere added at the effector:target (E:T) ratios indicated in individual
tested for production of Fr40 activity in CTL assays as describedfigures. Following a 4 hr incubation at 378C, cells were pelleted by
above.centrifugation of plates at 1,500 3 g for 5 min, and the cpm 51Cr
was determined in 100 ml of supernatant from each well. The peptide
competition assay was performed as above, except that competitor DNA Sequencing and Analysis
Plasmid DNA was isolated from subclones pE1D and pID6 andpeptides were added during the preincubation and remained
throughout the assay. LmSN and TSB were used undiluted; LemA sequenced using the Sequenase Version 2.0 DNA sequencing kit
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(United States Biochemical Corporation, Cleveland, Ohio). Addi- the secreted p60 antigen protect against Listeria monocytogenes
infection. J. Immunol. 154, 4642–4650.tional sequencing of pID6 was performed at the Murdock Molecular
Biology Facility by Dr. J. Strange (University of Montana, Missoula, Kaufmann, S.H., Rodewald, H.R., Hug, E., and De Libero, G. (1988).
Montana). Primers for sequencing included the M13/pUC primers Cloned Listeria monocytogenes specific non-MHC-restricted Lyt-21
(GIBCO–BRL) and custom oligonucleotides corresponding to inter- T cells with cytolytic and protective activity. J. Immunol. 140, 3173–
nal sequences. Insert DNA was sequenced at least twice and lemA 3179.
sequence was confirmed in both directions. Predictions of putative
Kocks, C., Gouin, E., Tabouret, M., Berche, P., Ohayon, H., andLemA membrane spanning regions and topology are based in part
Cossart, P. (1992). L. monocytogenes-induced actin assembly re-on results from sequence analysis using the ISREC (Swiss Institute
quires the actA gene product, a surface protein. Cell 68, 521–531.for ExperimentalCancer Research) bioinformatics server (Epalinges,
Kurlander, R.J., Shawar, S.M., Brown, M.L., and Rich, R.R. (1992).Switzerland).
Specialized role for a murine class I-b MHC molecule in prokaryotic
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